Forum Markets - Crunchbase Company Profile & Funding

Q: Who invested in Forum Markets?

Forum Markets has 15 investors including Peter Thiel And Harbour Island.

Q: When was the last funding round for Forum Markets?

Forum Markets closed its last funding round on obfuscated from a Post-IPO Debt round.

Q: How much funding has Forum Markets raised to date?

Forum Markets has raised obfuscated.

Overview

Forum Markets

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Forum Markets

CB Rank

52637

Forum Markets developing novel drugs for treating distinct inflammatory diseases.

Founded

obfuscation

Public

Post-IPO Debt

Menlo Park, California, United States

1-10

www.ethzilla.com

Biopharma

Biotechnology

Health Care

Life Science

Therapeutics

Funding Rounds

Post-IPO Debt

OBF

obfuscation

Post-IPO Debt

OBF

obfuscation

Post-IPO Equity

OBF

obfuscation

Key People

Raphael Mechoulam: Co-Founder
Ozan Pamir: CFO

Details

Legal Name

180 Life Sciences Corp.

Also Known As

CannBioRx Life Sciences, 180 Life Sciences, ETHZilla

Operating Status

Active

Stock Symbol

NASDAQ:ETHZ

Company Type

For Profit

Founders

Lawrence Steinman, Marc Feldmann, Raphael Mechoulam

About the Company

Forum Markets is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University, and Stanford University.

Phone Number

(650) 507-0669

Predictions & Insights

Growth Insight

See this Growth Insight

Forum Markets is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

α7nAChR Program

A drug development program focused on small molecule α7 nicotinic acetylcholine receptor agonists to activate the vagus nerve and reduce inflammation in diseases like ulcerative colitis.

Dupuytren’s Contracture Program

A therapeutic program repurposing anti-TNF drug adalimumab for early-stage Dupuytren’s Contracture to slow or prevent fibrous tissue formation in the hand.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Debt - Forum Markets	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Forum Markets	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Forum Markets	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Forum Markets	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Forum Markets	—	obfuscated obfuscation	—	Post-IPO Debt

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Debt - Forum Markets	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Forum Markets	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Forum Markets	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Forum Markets	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Forum Markets	—	obfuscated obfuscation	—	Post-IPO Debt

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Peter Thiel	Yes	Post-IPO Equity - Forum Markets	—
Peter Thiel	Yes	Post-IPO Equity - Forum Markets	—
Peter Thiel	Yes	Post-IPO Equity - Forum Markets	—
Peter Thiel	Yes	Post-IPO Equity - Forum Markets	—
Peter Thiel	Yes	Post-IPO Equity - Forum Markets	—

Investments

Investment Breakdown

Number of Investments

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Zippy	Yes	Corporate Round - Zippy	obfuscated obfuscation
obfuscated obfuscation	Zippy	Yes	Corporate Round - Zippy	obfuscated obfuscation
obfuscated obfuscation	Zippy	Yes	Corporate Round - Zippy	obfuscated obfuscation
obfuscated obfuscation	Zippy	Yes	Corporate Round - Zippy	obfuscated obfuscation
obfuscated obfuscation	Zippy	Yes	Corporate Round - Zippy	obfuscated obfuscation

Investment Breakdown

Number of Investments

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Zippy	Yes	Corporate Round - Zippy	obfuscated obfuscation
obfuscated obfuscation	Zippy	Yes	Corporate Round - Zippy	obfuscated obfuscation
obfuscated obfuscation	Zippy	Yes	Corporate Round - Zippy	obfuscated obfuscation
obfuscated obfuscation	Zippy	Yes	Corporate Round - Zippy	obfuscated obfuscation
obfuscated obfuscation	Zippy	Yes	Corporate Round - Zippy	obfuscated obfuscation